Research probes anticancer mechanisms of Polyphenon E.
Graff
Steve
S
D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology*; D002392:Catechin / Q000031:analogs & derivatives* / Q000494:pharmacology; D002986:Clinical Trials as Topic; D019938:Cyclin D1 / Q000187:drug effects / Q000378:metabolism; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000188:drug therapy; D054547:National Cancer Institute (U.S.); D009369:Neoplasms / Q000188:drug therapy* / Q000378:metabolism; D015398:Signal Transduction / Q000187:drug effects; D014481:United States; D014486:United States Food and Drug Administration
D000970:Antineoplastic Agents; D019938:Cyclin D1; D002392:Catechin; C472086:polyphenon E